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Decision-making in regard to elective repair of abdominal aortic aneurysms (AAA) requires careful assessment of factors
that influence rupture risk, operative mortality, and life expectancy. Individualized consideration of these factors in each
patient is essential, and the role of patient preference is of increasing importance. It is not possible or appropriate to
recommend a single threshold diameter for intervention which can be generalized to all patients. Based upon the best
available current evidence, 5.5 cm is the best threshold for repair in an “average” patient. However, subsets of younger,
good-risk patients or aneurysms at higher rupture risk may be identified in whom repair at smaller sizes is justified.
Conversely, delay in repair until larger diameter may be best for older, higher-risk patients, especially if endovascular
repair is not possible. Intervention at diameter <5.5 cm appears indicated in women with AAA.
If a patient has suitable anatomy, endovascular repair may be considered, and it is most advantageous for older,
higher-risk patients or patients with a hostile abdomen or other technical factors that may complicate standard open
repair. With endovascular repair, perioperative morbidity and recovery time are clearly reduced; however, there is a higher
reintervention rate, increased surveillance burden, and a small but ongoing risk of AAA rupture. There is no justification
at present for different indications for endovascular repair, such as earlier treatment of smaller AAA. Until long-term
outcome of endoluminal repair is better defined and results of randomized trials available, the choice between
endovascular and open repair will continue to rely heavily on patient preference. (J Vasc Surg 2003;37:1106-17.)
A decade has elapsed since the Joint Vascular Societies
published recommendations on the operative management
of abdominal aortic aneurysms (AAA).1 During this time,
much further information regarding the anticipated natural
history of unoperated AAA and outcome of conventional
open surgical AAA repair has been accumulated.2 Two
carefully performed prospective randomized trials have
been published, with findings that challenge many previ-
ously held indications for surgical repair.3,4 Finally, within
the past 10 years endovascular AAA repair has evolved and
currently plays a major role in AAA management.5 Thus it
is clear that revised guidelines for AAA management are
necessary.
Guidelines are meant to assist physicians in clinical
decision making and aim to improve effectiveness of care as
well as optimize patient outcomes. In contemporary prac-
tice, there is growing emphasis on evidence-based manage-
ment, and guidelines must therefore be based upon the best
available data. It is well recognized that the best evidence
(Level I) is derived from properly designed and conducted
prospective randomized trials.6 In regard to AAA manage-
ment, there are few such trials, and therefore many recom-
mendations are by necessity the result of consensus of
participating experts. It should be emphasized that guide-
lines are not meant to be dictates but rather a framework
within which clinicians bring their own judgment in con-
sidering unique individual patient circumstances and per-
sonal values.
RANDOMIZED TRIALS
Level I evidence for the treatment of small AAA has
been provided by two randomized prospective clinical trails
conducted in the United Kingdom and the United
States.3,4 Design and results of both trials were remarkably
similar. The United Kingdom (UK) Small Aneurysm Trial3
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and the Aneurysm Detection and Management Study
(ADAM),4 conducted at VA Medical Centers in the US,
each examined more than 1000 patients with AAA of 4.0
cm to 5.4 cm in maximal diameter, randomly assigned to
early elective open surgical repair or ultrasonographic or
computed tomography (CT) surveillance every 3 to 6
months. In the surveillance cohort, operation was recom-
mended if the AAA expanded to5.5 cm, enlarged1 cm
in 1 year, or became symptomatic. The primary endpoint
was death, and mortality analyses were done by intention to
treat. Mean follow-up was 4.6 years for the UK Small
Aneurysm Trial and 4.8 years for the ADAM trial.
Both trials concluded that surveillance of AAA of 4.0
cm to 5.5 cm was safe in compliant patients, and that early
surgery did not result in any long-term survival advantage.
While operative mortality in the UK trial was higher (5.8%)
than had been anticipated, perioperative mortality in the
ADAM trial was only 2.7%. Thus, while the UK trial
conclusions had been challenged by some because of the
relatively high operative mortality, the ADAM trial effec-
tively overcame this concern.
It is important to note, however, that60% of patients
in the surveillance group in both studies eventually under-
went surgical repair of their AAA because of expansion or
development of symptoms by the end of the study. This
eventual need for surgical repair was also dependent on the
size of the AAA at the time of randomization. In the
ADAM trial, for instance, 81% of patients with AAA of 5.0
cm to 5.4 cm at entry into the study required surgical repair
within the 4.9-year follow-up period.4 Rupture risk for
AAA in the surveillance group was low in both trials (1%
per year). One must be cautious in inferring that this figure
accurately indicates the natural history of untreated AAA
5.5 cm, since 75% of patients in the UK trial, for example,
had AAA 5.0 cm, and more than 60% of those in the
surveillance group were operated on within the study pe-
riod following developments considered to signify an in-
creased chance of rupture. Therefore, to interpret these
data as accurately reflecting the natural history of AAA up
to 5.5 cm is likely somewhat misleading.7
In a sequel to their initial report, the UK Small Aneu-
rysm Trial participants have recently described their find-
ings of extended 10-year (1991-2001) follow-up of surviv-
ing UK trial patients.8 By the end of 2001, an additional
12% of the surveillance group had undergone surgical
repair, for a total of 74% of patients in this cohort during the
9-year observation of the trial. This emphasizes the fact that
for many patients assigned to watchful waiting, the ques-
tion is often not “if” but rather “when” aneurysm repair
will be necessary.9 In this scenario, patient preferences
should be a guiding consideration. These extended trial
data revealed worse late survival in the surveillance group;
survival curves crossed at about 3 years. At 8 years, the
estimated risk of death was 7.2% lower in the early-surgery
group than in the surveillance cohort (P  .03). However,
rupture of unrepaired AAA caused only a small proportion
of deaths (6%), so that other explanations must be sought
to explain the small late survival advantage in the early
surgery group. The trial participants theorized that this
difference may be attributable to a higher rate of smoking
cessation and other favorable lifestyle changes in the sur-
gery group. An additional important observation was that
death was attributable to ruptured AAA in 5% of men who
died but 14% of women who died. The risk of rupture was
4 times as high among women as among men. The trial
participants concluded that the threshold of 5.5-cm diam-
eter may be too high for women.
INDIVIDUAL DECISION-MAKING
The goal of elective AAA repair is to prevent rupture
and prolong life. To be most effective, it should be per-
formed when the rupture risk is high compared with oper-
ative risk, in patients who will live long enough to enjoy the
long-term benefit. Thus, decision making involved in se-
lecting patients for AAA repair is influenced primarily by
estimates of (1) aneurysm rupture risk, (2) elective opera-
tive mortality risk, (3) life expectancy, and (4) patient
preference. In the absence of truly accurate data regarding
many of these variables, decision making is often a complex
and uncertain process. It is increasingly recognized that
patient preference, after a complete review of options and
anticipated results (true informed consent), must be a very
important component in this decision-making process.
RUPTURE RISK
Accurate data on rupture risk are likely the least precise
of the several variables which need to be assessed in the
decision-making process. This is due to the fact that in the
past 3 decades few patients have been followed without
intervention; hence, the true natural history of untreated
AAA remains somewhat poorly defined.10
It is accepted that AAA diameter is the best predictor of
rupture risk. This was established by natural history studies
before the era of widespread elective repair as well as several
autopsy studies. The variability of estimates of rupture risk
for particular AAA diameters cited in the literature reflects
differences in other factors besides maximal diameter which
may vary considerably from series to series, and illustrates
that other factors in addition to absolute size must be taken
into account in each individual case.11-13
It is clear that there is a substantial increase in rupture
risk as AAA diameter increases from 5 cm to 6 cm. In the
only population-based study available, Nevitt et al14 re-
ported no rupture during 5-year follow-up for AAAs 5
cm, but a 5% annual rupture risk for AAA 5 cm at initial
presentation. In a more recent analysis of these data, Reed
et al estimated annual rupture risk (with 95% confidence
intervals) to be 0% (0%-5%) for AAA 4 cm, 1% (0%-5%)
per year for 4.0-4.9 cm AAAs, 11% (1%-21%) per year for
5.0-5.9 cm AAAs and 26% (7%-46%) per year for 6.0-6.9
cm AAAs.15 Similar estimates were obtained from the
larger UK Small Aneurysm Trial, where the annual rupture
rate was calculated as 0.3% for AAAs4 cm diameter, 1.5%
for 4.0-4.9 cm AAAs, and 6.5% for 5.0-5.9 cm AAAs.16 It
is possible that these studies underestimate rupture risk
since some AAAs underwent elective repair for rapid expan-
JOURNAL OF VASCULAR SURGERY
Volume 37, Number 5 Brewster et al 1107
sion or symptoms and so were censored before rupture
could occur, as previously noted.7 This issue was consid-
ered by Scott et al17 in analysis of 166 small AAAs with an
annual rupture rate of 0.7% for 3.0-4.4 cm AAAs and 1.7%
for 4.5-4.9 cm AAAs. Since some AAAs underwent elective
repair, they reported maximum possible rupture rates (ac-
tual rupture rate plus elective surgery rate) of 2.1% for
3.0-4.4 cm AAAs and 10.2% for 4.5-5.9 cm AAAs.
Although most patients with larger AAAs undergo
elective repair, Jones et al18 reported annual rupture rates of
12% for 5.0-5.9 cm AAAs and 14% for 6 cm AAAs in
higher-risk or older patients who refused elective repair.
Similar striking data relative to rupture risk of large AAA
were recently reported by Lederle and colleagues from the
ADAM trial data. The 1-year incidence of probable rupture
by initial AAA diameter was 9.4% for AAA of 5.5 cm to 5.9
cm, 10.2% for AAA of 6.0 cm to 6.9 cm, and 32.5% for AAA
of 7.0 cm or more.19 Thus, although there is agreement
that rupture risk is very low for AAAs5 cm diameter, and
increases substantially by 6-cm diameter, there is consider-
able variation in estimates of actual rupture risk reported in
the literature for any specific AAA diameter (Table I).
The simple observation that not all AAAs rupture at a
specific diameter indicates that other patient- or aneurysm-
specific variables also affect rupture risk. In a multivariate
analysis, Cronenwett et al20 observed that increased initial
diameter, hypertension, and chronic obstructive pulmo-
nary disease (COPD) were independently predictive of
rupture in patients with small AAAs. By comparing patients
with ruptured and intact AAAs at autopsy, Sterpetti et al21
concluded that larger initial AAA size, hypertension, and
bronchiectasis were independently associated with AAA
rupture. Smoking was identified as a risk factor for rupture
in a study of male civil servants in England where the
relative risk of death from AAA rupture increased 4.6-fold
for cigarette smokers, 2.4-fold for cigar smokers and fully
14.6-fold for smokers of hand-rolled cigarettes.22
Important new information concerning AAA rupture
risk has been obtained from the UK Small Aneurysm Trial
data. In a cohort of 2257 patients with 4.0-5.5 cm AAAs,
the relative risk of rupture was independently increased by
female gender (3.0), larger initial diameter (2.9 per
cm), current smoking (1.5), worse COPD (0.6 per L
FEV1), and higher mean arterial pressure (1.02 per mm
Hg).16 In a review of ruptured AAAs from Finland, 24% of
women with rupture had AAA 5.5 cm.23 These results
confirm previous observations and suggest that a 5-cm
diameter AAA in a woman has an equivalent risk to a 6-cm
diameter AAA in a man.
Not only does a positive family history of AAA increase
the prevalence of AAAs in other first-degree relatives
(FDRs), but it also appears to increase rupture risk. Darling
et al24 reported that the frequency of ruptured AAAs in-
creased with the number of FDRs who have AAAs: 15%
with 2 FDRs, 29% with 3 FDRs, and 36% with 4 FDRs.
Verloes et al25 found that the rupture rate was 32% in
patients with familial aneurysms versus 9% in patients with
sporadic aneurysms. However, these studies did not con-
sider other potentially confounding factors, such as AAA
size, which might have been different in the familial group.
In addition to AAA diameter, many surgeons consider
the ratio of diameter to the proximal normal aorta poten-
tially important in determining rupture risk. Intuitively, a
4-cm AAA in a patient with a 1.5-cm diameter native aorta
would be at greater risk of rupture than a comparable 4-cm
AAA in a patient with a native aortic diameter of 2.5 cm.
The validity of this concept, however, has not been proven.
Ouriel et al26 suggested that a relative comparison between
aortic diameter and the diameter of the third lumbar verte-
bra may increase the accuracy for predicting rupture risk, by
adjusting for differences in body size. The improvement in
prediction accuracy appears minimal, however, when com-
pared with absolute AAA diameter.
Clinical opinion also holds that eccentric or saccular
aneurysms represent greater rupture risk than more diffuse,
cylindrical aneurysms. Using computer modeling, Vorp et
al27 found that wall stress is substantially increased by an
asymmetric bulge in AAAs. In fact, the influence of asym-
metry was as important as diameter over the clinically
relevant range tested. Fillinger et al have extended this
concept to calculate wall stress in AAAs using finite element
analysis of three-dimensional CT scans.28 They found sig-
nificantly higher wall stress in ruptured or symptomatic
AAAs as compared with elective AAAs. In fact, the smallest
ruptured aneurysm (4.8-cm diameter) had a calculated wall
stress equal to that of a 6.3-cm diameter AAA in the elective
repair group. This suggests that calculated wall stress may
become a valuable predictor of rupture risk as these tech-
niques become more widely available.
Localized outpouchings or “blebs”, ranging from 5
mm to 30 mm in size, can be observed on AAAs intraop-
eratively or on CT scans. These areas of focal wall weakness
demonstrate marked thinning of the medial elastin, and
have been suggested to increase rupture risk.29 Faggioli et
al30 found that impending rupture was significantly greater
in patients with such “blisters” than those without (71% vs
29%). The effect of intraluminal thrombus on AAA rupture
risk is debated, but a recent study by Schurink et al31 found
that thrombus within an aneurysm does not reduce either
mean or pulse pressure near the aneurysm wall and thus
does not likely affect rupture risk.
Although rapid AAA expansion is presumed to increase
rupture risk, it is difficult to separate this effect from the
influence of expansion rate on absolute diameter, which
alone could increase rupture risk. AAAs in the 4-cm to 6-cm
Table I. Estimated annual rupture risk
AAA diameter (cm) Rupture risk (%/y)
4 0
4-5 0.5-5
5-6 3-15
6-7 10-20
7-8 20-40
8 30-50
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diameter range expand approximately 10% per
year.12,20,32,33 Two studies have reported that expansion
rate was greater in ruptured than intact AAAs, but these
ruptured AAAs were also larger.12,34 Even though not
proven conclusively, rapid AAA expansion (1 cm/y) is
generally regarded as a risk factor for rupture and is often
used as a criterion for elective repair of small AAAs.
Although average AAA expansion rate can be estimated
for a large population, it is important to realize that indi-
vidual AAAs behave in a more erratic fashion. Periods of
rapid expansion may be interspersed with periods of slower
expansion and are not predictable. Chang et al35 found that
in addition to large initial AAA diameter, rapid expansion is
independently associated with advanced age, smoking, se-
vere cardiac disease, and stroke. The influence of smoking
has been confirmed by others.36,37 In addition to these
factors, hypertension and pulse pressure have been identi-
fied as independent predictors of more rapid expansion
rate.20,33,34 Finally, increased thrombus content within an
AAA and the extent of the aneurysm wall in contact with
thrombus appear to be associated with more rapid expan-
sion.38,39
Although there is no precise formula that incorporates
the risk factors described above to calculate exact rupture
risk, they can be used to categorize rupture risk as low,
average, or high (Table II).
OPERATIVE RISK
As with rupture risk, reported operative mortality of
conventional open surgical repair of AAA varies consider-
ably in the literature. Much of this variability is related to
the type of study reported, that is, hospital-based versus
population-based series.41 Many referral-based series from
individual centers of excellence describe 30-day periopera-
tive mortality of only 1% to 5% following elective open
infrarenal AAA repair.42-44 Such excellent results demon-
strate the low mortality rates that can be achieved in se-
lected referral centers by skilled, well-trained, experienced
surgeons. However, these data cannot be generalized to
larger populations. Thus, it is now well documented that
many recent population-based series employing statewide
or national databases indicate higher mortality, in the 4% to
8% range even in contemporary practice.41,45-53 A review of
64 studies on this subject found an average mortality rate of
5.5%.33 This is consistent with the findings of the UK Small
Aneurysm Trial (5.8%),3 1996 US Medicare data (5.5%),2
and the largest available database in the report of Heller et
al (5.6%).47 Results of other population-based studies are
similar.54-60 Surprisingly, there also appears to have been
little improvement in mortality rates for elective or rup-
tured AAA repair over the past two decades.33,47,49
Although such generalized experience is important,
decision making for individual patients requires a more
patient-specific approach. Using individualized estimates of
operative risk may clearly identify low- and high-risk sub-
sets of patients and allow more accurate predictions and
clinical decisions. Several factors need to be considered. In
the Canadian Aneurysm Study, the most significant vari-
ables were electrocardiographic (EKG) evidence of isch-
emia, COPD, and elevated creatinine.61 If none of these
risk factors was present, operative mortality was 1.9%,
whereas if all three were noted in a specific patient, 30-day
mortality was 50% (Table III, online only). Using the same
database from the Canadian Aneurysm Study, an alterna-
tive predictive model of operative mortality after AAA
repair, which includes the patients’ age, has also been
developed. Postoperative mortality ranges from 1% to 46%
(Table IV, online only). Patient age has also been shown to
be an important predictor in the UK study.62 In this study,
the overall postoperative mortality rate was 5.6%. In their
subanalsysis, postoperative mortality risk was significantly
associated with older age, higher serum creatinine level,
and lower forced expiratory volume in 1 second (FEV1).
The predicted postoperative mortality risk ranged from
2.7% in younger patients with normal creatinine levels and
good FEV1 to 7.8% in older patients with elevated creati-
nine levels and reduced FEV1. The impact of advancing age
has also been shown in many other studies.53,54
Similarly, a meta-analysis by Steyerberg et al63 identi-
fied independent risk factors for perioperative mortality of
elective open AAA repair (Table V). Based on this analysis,
Steyerberg et al also developed a clinical prediction model
to estimate the operative mortality risk for individual pa-
tients using these factors (Table VI, online only). This
scoring system takes into account the independent risk
factors plus the average overall elective mortality rate from
a specific medical center. Using their scoring system, the
predicted operative mortality for a 70-year-old man in a
medical center with an average operative mortality rate of
5% could range from 2% if no risk factors were present to
Table II. Rupture risk
Low risk Average risk High risk
Diameter 5 cm 5-6 cm 6 cm
Expansion 0.3 cm/y 0.3-0.6 cm/y 0.6 cm/y
Smoking/COPD None, mild Moderate Severe/steroids
Family history No relatives One relative Numerous relatives
Hypertension Normal blood pressure Controlled Poorly controlled
Shape Fusiform Saccular Very eccentric
Wall stress Low (35 N/cm2) Mdm. (40 N/cm2) High (45 N/cm2)
Gender - Male Female
Reprinted with permission from Schermerhorn ML, Cronenwett JL. Decision making in vascular surgery. Philadelphia: WB Saunders Co; 2001.
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more than 40% if cardiac, renal, and pulmonary comorbidi-
ties were all present.
Similar risk factors, as well as the impact of patient-
specific variables and the cumulative effect of their influence
on operative risk, have also been documented in other
reports.47,52,64,65 In all series, cardiac complications are the
predominant cause of perioperative deaths. For example, in
Hertzer’s report of the Cleveland Vascular Society experi-
ence, a mortality rate of 2.9% was observed if patients had a
negative history of cardiac disease and normal EKG, 5.2% if
either history or EKG was abnormal, and 9.7% if both
history and EKG were postive.55 In the Canadian Aneu-
rysm Study, patients without evidence of coronary artery
disease had a 0.8% mortality rate from cardiac disease
compared with 6.2% if any stigmata of coronary disease
were present.45
Additional patient-specific factors need to be consid-
ered in estimating perioperative mortality risk in addition to
age and the presence of cardiac, renal, or pulmonary co-
morbidities. Several studies have now documented in-
creased death rates in female patients, with an odds ratio of
approximately 1.5 greater risk.52,56,63,66 It is also strikingly
clear that mortality risk is strongly influenced by surgeon
training and both surgeon and hospital volume of AAA
repair.2,52,53,57-59,67 For example, analysis of 1996 US
Medicare data revealed 30-day operative mortality of 7.9%
for low-volume (3 or fewer/y) surgeons as compared with
4.0% for high-volume (11 or more repairs/y) surgeons.2 In
1996, 60% of surgeons who performed elective AAA repair
were low-volume surgeons.2 Similar findings related to
specialty training (vascular surgeons versus general sur-
geons) and hospital volume have also been ob-
served.57,59,67 Thus, it is important for a surgeon to know
his or her own individual results in assessing risk and
making clinical decisions.
Finally, operative mortality risk is influenced by ana-
tomic or pathologic features of an AAA. Such features
present technical difficulties and lead to potential compli-
cations during graft implantation and hence may impact
mortality risk. Extensive atheromatous disease, thrombus
formation, or severe mural calcification at sites of proximal
or distal anastomosis or clamp application are examples,
although actual quantification of the influence of such
considerations on the risk of complications or mortality is
difficult. Certainly extension of aneurysmal disease to a
juxtarenal level, requiring suprarenal clamping for repair, is
associated with increased morbidity and mortality due to
the more extensive and complex dissection necessary,
obligatory renal ischemia time, and increased hemody-
namic stresses secondary to more proximal clamping.68-72
Similarly, inflammatory abdominal aortic aneurysms, with
adhesion of adjacent bowel, left renal vein, and/or ureters
often present technical challenges and are associated with
increased morbidity and mortality.73,74 A major venous
anomaly may occur in as much as 3% to 5% of AAAs and
increases the risk of hemorrhage during open surgical re-
pair.75-77 Thus, mortality may be somewhat higher, partic-
ularly when such anomalies are not recognized preopera-
tively and hence unanticipated during repair.
Again, utilizing an individualized assessment of risk
factors for each specific patient allows categorization of
operative mortality risk into low (1%-3%), moderate (3%-
7%), and high (at least 5%-10% or greater) categories which
may be useful on a practical clinical level in terms of
decision making (Table VII).
LIFE EXPECTANCY
After estimating rupture risk and anticipated mortality
of repair, decision making must also consider the patient’s
life expectancy. On a population basis, age is the best
predictor of life expectancy, which in the United States is
approximately 18 years for a 60-year-old man decreasing to
5 years for an 85-year-old man.78 Obviously, however, for
an individual patient, other factors that influence life ex-
pectancy must also be considered. Most important, of
course, are comorbid medical conditions present in each
patient.
In general, 5-year survival following AAA repair is
reduced compared to age- and sex-matched population
data, averaging approximately 60% to 65% as compared
with 75% to 80% anticipated.79-84 Over the past 2 decades,
it appears that the survival rate has not improved signifi-
cantly, perhaps because selecting higher-risk patients has
offset improvements in surgical, medical, and anesthetic
management.
As with determination of the risks of AAA rupture and
perioperative mortality, individual variables play a consid-
erable role in estimating life expectancy. In the late results
of the Canadian Aneurysm Trial, 5-year survival ranged
from 27% to 85%.81 Higher 5-year survival rates were
associated with younger age, no history of congestive heart
failure, no or minimal angina, no EKG evidence of isch-
emia, old infarction, evidence of left ventricular hypertro-
phy or strain or arrhythmia, no significant COPD, and
creatinine 1.5. In the large series from the Cleveland
Clinic, the predictors of late mortality were age 75 years,
a previous history of coronary artery disease (especially with
congestive heart failure), chronic pulmonary disease, or
creatinine 2.0.44 Data from Emory University are simi-
lar.85
Table V. Independent risk factors for operative mortality
after elective abdominal aortic aneurysm repair
Risk factor Odds ratio 95% CI
Creatinine 1.8 mg/dL 3.3 1.5-7.5
Congestive heart failure 2.3 1.1-5.2
ECG ischemia 2.2 1.0-5.1
Pulmonary dysfunction 1.9 1.0-3.8
Older age (per decade) 1.5 1.2-1.8
Female gender 1.5 0.7-3.0
Reprinted with permission from Steyerberg et al. Arch Intern Med 1995;
155:1998-2004. Copyright 1995, American Medical Association.
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PATIENT PREFERENCE
Active patient participation in the decision-making pro-
cess is of paramount importance. This is particularly true for
the option of endoluminal repair. Some patients are not
psychologically suited to having an untreated AAA with an
ill-defined rupture risk. In addition, young patients with
AAA in the 4.0-cm to 5.5-cm range will very likely come to
eventual repair at some point of follow-up, as demonstrated
by several series of selective surgery in which 60% to 75% of
patients under surveillance eventually underwent re-
pair.3,4,20,86 The need for future surgery is also strongly
influenced by the size of the AAA at the time of diagnosis.
In the original UK Small Aneurysm Trial, 53% of patients
with aneurysm 4.5 cm to 4.9 cm at the time of randomiza-
tion underwent surgical repair within the mean 4.9 years of
follow-up, while 81% of those with AAA 5.0 cm to 5.4 cm
in diameter came to surgery before conclusion of the trial.3
Hence, it may be the patient’s preference to proceed with
repair at a smaller size threshold if operative risk is low. In
this regard, follow-up outcomes surveys in the UK Small
Aneurysm Trial documented that patients randomized to
early surgery had more positive improvements in current
health perceptions and health-related quality of life than
those patients in the surveillance group.87 Because the
rupture risk is relatively low for AAA5.5 cm, it should be
emphasized that operative results must be outstanding to
support early repair. Finally, close patient follow-up
achieved in many trials may not be attainable in “real-
world” everyday practice. It has been well demonstrated
that not all patients will be compliant with the close surveil-
lance necessary in an effective program of watchful wait-
ing.88 Hence early surgery may be preferable in such pa-
tients.
DECISION ANALYSIS MODELS
Because of the complex interaction among variables
that influence AAA management, formal decision-analysis
models have been constructed to aid in risk comparisons.
Such models demonstrate that for a 70-year-old man with
average life expectancy and average elective operative mor-
tality (5%), AAA repair will improve life expectancy if
annual rupture risk exceeds 1.5%,89 which is the estimated
rupture risk for 4.5-cm to 5.0-cm AAA in many studies. For
younger patients, the “threshold” AAA diameter (and rup-
ture risk) that justifies elective repair is lower, whereas in
older patients the threshold diameter for elective repair
increases.
In a recent decision analysis study employing data from
the UK Trial, Schermerhorn and colleagues concluded that
early surgery may be cost effective for selected patients with
small AAA, particularly younger patients (72 years of age)
with larger AAAs (4.5 cm). They emphasize, however,
that because the gains in life expectancy are relatively small,
clinical decision making should be strongly guided by
patient preferences.90
ENDOVASCULAR REPAIR
Endovascular aneurysm repair (EVAR) emerged in the
early 1990s as an alternative treatment for AAA, and has
quickly gained an important role in current clinical man-
agement.5 Many studies have demonstrated equivalent
early safety and efficacy of EVAR as compared with conven-
tional open surgical repair.91-95 In addition, many short-
term benefits of EVAR have been documented, including
reduced intensive care unit and hospital lengths of stay
(LOS), reduced blood loss, fewer major complications, and
more rapid recovery.91-95 Studies with longer follow-up are
inconsistent, however; some mid-term reports suggest
equivalent outcomes at 3 to 6 years,96-99 whereas others
have raised concerns about the durability of EVAR and
highlight the problems of endoleak, need for late reinter-
ventions and/or conversion to open repair, as well as the
ultimate failure—rupture.100-107 At present, there are no
randomized prospective clinical trials comparing EVAR
with standard open repair, or to continued observation,
although several such studies are underway.108
Morbidity and mortality. Because of its less invasive
nature, most investigators feel that EVAR allows treatment
of AAA with lower perioperative mortality risk than con-
ventional open repair in comparable patients. This has not
Table VII. Operative mortality risk of open AAA repair
Good risk Moderate risk High risk
Age 70 y Age 70-80 y Age 80 y
Physically active Active Inactive, poor stamina
No clinically overt cardiac disease Stable coronary disease; remote MI;
EF 35%
Significant coronary disease; recent MI;
frequent angina; CHF; EF 25%
No other significant comorbidities Mild COPD Limiting COPD; dyspnea at rest; O2
dependency; FEV1 1 L/sec
Creatinine 2.0-3.0
Normal anatomy Adverse anatomy or AAA
characteristics
Creatinine 3
No adverse AAA characteristics Liver disease (1 PT; albumin 2)
Anticipated operative mortality, 1%-3% Anticipated operative mortality, 3%-7% Anticipated operative mortality, at least
5%-10%; each comorbid condition
adding approximately 3%-5%
mortality risk
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been conclusively demonstrated, however, as currently
available data from Food and Drug Administration trials, as
well as registry data and other series, have not shown a
statistically significant difference in perioperative mortality.
Similarly, no improvement in long-term survival has been
reported to date for EVAR as compared with standard open
repair.92,95-97,109,110
Clearly perioperative morbidity is reduced with EVAR
as compared with open operation, with significantly fewer
major adverse events. The absolute reduction in complica-
tions depends upon the level of stratification of severity, but
there are consistent, clinically relevant, relative reductions
in complication rates with EVAR, ranging from 30% to
70%. These reductions are primarily in cardiac, pulmonary,
and gastrointestinal organ systems. While some earlier
studies have found an increased incidence of renal and
vascular complications, more recent trials with more expe-
rienced operators, smaller delivery systems, and improved
device designs have shown no differences in these areas. In
addition, EVAR should substantially reduce the incidence
of operation-related erectile dysfunction which occurs fol-
lowing standard open AAA repair in a substantial percent-
age of patients with normal function prior to surgery.111
As a consequence of the reduced incidence, as well as
severity, of perioperative complications and the less invasive
nature of EVAR, recovery time is markedly quicker as
compared with conventional open repair.91,95 Indeed, re-
covery time from repair is one of the most striking differ-
ences between EVAR and open operation for AAA and
highlights the sobering review of Williamson et al112 who
observed that up to one third of patients undergoing
standard open AAA repair had failed to fully recover at a
mean follow-up of 34 months, and 18% of patients stated
they would not undergo AAA repair again knowing the
recovery process, an outcome that is clearly age-related.
Because of the reduced morbidity and quicker recovery
associated with EVAR, many authorities believe that this
method of treatment is particularly beneficial to older,
higher-risk patients who have appropriate anatomy.113-115
Endoleak. Mid-term results indicate a generally fa-
vorable impact of EVAR on the anticipated natural history
of AAA, with limitation of AAA expansion in 80% to 90% of
patients and prevention of rupture in 95% to 98%.5,97-99,116
However, patients must understand potential shortcom-
ings of EVAR that represent a tradeoff for the benefits of
less invasive therapy.5,117 These include persistent or new-
ly-developing late endoleak rates of approximately 10% to
20%.118
The true clinical significance of endoleak remains
poorly defined, however, and this is indeed a complex and
controversial topic.119-123 Several studies have shown poor
correlation between endoleak and outcome, and many
authorities believe that the most common variety of en-
doleak, Type 2 retrograde branch flow, rarely causes ad-
verse clinical consequences.124-126 In contrast, there is
general consensus that Type 1 and 3 leaks are clearly
associated with adverse events such as continued AAA
enlargement and ongoing rupture risk.119,126,127 It is also
now recognized that aneurysm expansion and even rupture
may occur in the absence of a discernible endoleak, a
phenomenon which has been termed “endotension.”128
Secondary interventions. While AAA sac maximal
diameter shrinkage was initially received with enthusiasm,
longer follow-up has demonstrated that this may be asso-
ciated with later adverse effects upon the endograft includ-
ing limb kinkage or occlusion, modular junctional separa-
tions, device migration, or related problems.129-131 Such
consequences of late morphologic changes to the AAA
have been termed the “paradox of success.”117 Structural
deterioration of endoluminal devices appears to increase
with time and can also be a source of treatment fail-
ure.98,100 There is some optimism, however, that such
problems will be less frequent in the more recently devel-
oped second- and third-generation devices.132,133
As a consequence of such potentially adverse events
following EVAR, it is well recognized that secondary rein-
terventions are required in as much as 10% of patients per
year.134 The majority of such reinterventions are catheter-
based procedures rather than open surgical operations and
are generally successful in correcting the problem and
maintaining the integrity of the endovascular re-
pair.98,134,135 Such procedures most often involve stenting
for reduced limb flow, coil embolization for endoleaks, or
placement of further proximal or distal stent-graft extender
components for migration or endoleak. While less invasive
and generally successful, the high rate of such secondary
interventions contrasts strikingly with conventional open
repair in which reintervention rates are less than 2% in the
first 5 years. While late reoperation may be required in some
patients following open repair, the need for reoperation is
generally a late phenomenon and often occurs a decade or
more after the initial operative procedure.136-139 Thus,
although the need for catheter-based reintervention does
not necessarily indicate failure of EVAR, it is clearly an issue
that patients must understand and accept if they elect to
undergo endovascular treatment of their AAA.98
Conversion to open repair. In initial experience with
EVAR, early periprocedural conversion to open operation
was necessary in as much as 10% of cases for a variety of
technical difficulties or procedural complica-
tions.91,94,98,127 The need for conversion was most often
related to poor patient selection, nonflexible large-caliber
first-generation devices, and relative operator inexperi-
ence.140 With advancements in all these areas, early conver-
sions are now rare.5,141,142 Late conversions, however,
continue to be required in 1% to 2% of patients per year.103
Late conversions to open repair are most commonly re-
quired for progressive AAA enlargement, device migration,
structural failure of the endograft, infection of the prosthe-
sis, and, of course, late AAA rupture. As compared with
standard open operative AAA repair, late conversion carries
a somewhat higher morbidity and mortality risk due to the
frequent need for suprarenal clamping, more extensive
dissection, and other potential technical pitfalls, and it is
clearly associated with increased risk and worse out-
comes.109,140-142
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AAA rupture. The ultimate failure of endoluminal
AAA repair is the occurrence of aneurysm rupture despite a
seemingly technically successful endovascular repair. While
no ruptures were reported in initial reports of early devices,
nearly all devices have, by now, had some aneurysm rup-
tures after longer follow-up, particularly outside of the
controlled circumstances of clinical trials.105 Analyses of
many of these cases have revealed potentially avoidable
causes such as poor patient selection, operator deployment
errors, or unrecognized/untreated endoleaks.102,105,143
Aorto-aortic tube endografts and unapproved devices with
frequent structural failures have an unacceptably high risk
of late rupture and have largely been abandoned. AAA
rupture risk in properly selected patients, treated appropri-
ately with approved bifurcated devices, is about 0.5% at 3 to
4 years.97,98,105,110 The Eurostar Registry experience,
which contains a large number of first- and second-gener-
ation devices, indicates a cumulative rupture risk of approx-
imately 1% per year.103 This possibility underscores the
importance of continued postprocedural surveillance for
patients undergoing EVAR. Patients must understand and
accept this more intensive follow-up surveillance burden,
potential need for reintervention, and less certain repair of
their AAA if they wish to proceed with EVAR.144
CHOOSING ENDOVASCULAR VERSUS OPEN
AAA REPAIR
The availability of EVAR has added additional consid-
erations and complexity to surgical decision making for
AAA repair. With the lower mortality and morbidity of
EVAR, this approach could be assumed to justify repair of
smaller aneurysms if they have favorable anatomy. How-
ever, at present the late complications and higher reinter-
vention rate offsets this potential advantage, and indica-
tions for repair should remain the same.145 A recent
decision analysis by Schermerhorn et al146 using Eurostar
data for endovascular repair, and Medicare data for open
repair, found little difference in quality-adjusted life expect-
ancy between the two strategies. Although EVAR was
slightly more beneficial (except in younger patients), small
variations in many key variables changed the optimal strat-
egy for any given patient.
Thus, decisions regarding the optimal method of AAA
repair in an individual patient will remain uncertain until
long-term outcomes of EVAR are more clearly established.
These data will be best obtained from large prospective
registries employing prospective pooled data and contin-
ued careful scientific analysis.147 Randomized control trials
comparing EVAR with standard open operation or best
medical therapy in very high-risk patients will hopefully
provide more definitive information and thereby facilitate
the decision-making process. For now, the choice between
EVAR and conventional open surgery will continue to rely
heavily on patient preference. This is valid, however, only if
patients are fully informed and aware of potential benefits as
well as disadvantages of both methods. This remains an
important responsibility of the treating surgeon.
CURRENT RECOMMENDATIONS FOR AAA
REPAIR
1. The arbitrary setting of a single threshold diameter for
elective AAA repair applicable to all patients is not
appropriate, as the decision for repair must be individ-
ualized in each case.
2. Randomized trials have shown that the risk of rupture
of small (5 cm) AAA is quite low, and that a policy of
careful surveillance up to a diameter of 5.5 cm is safe,
unless rapid expansion (1 cm/y) or symptoms de-
velop. However, early surgery is comparable to surveil-
lance with later surgery, so that patient preference is
important, especially for AAA 4.5 cm to 5.5 cm in
diameter.
3. Based upon the best available current evidence, 5.5-cm
diameter appears to be an appropriate threshold for
repair in an “average” patient. However, subsets of
younger low-risk patients, with long projected life-
expectancy, may prefer early repair. If the surgeon’s
personal documented operative mortality rate is low,
repair may be indicated at smaller sizes (4.5-5.5 cm) if
that is the patient’s preference.
4. For women, or AAA with greater than average rupture
risk, elective repair at 4.5 cm to 5.0 cm is an appropri-
ate threshold for repair.
5. For high-risk patients, delay in repair until larger diam-
eter is warranted, especially if EVAR is not possible.
6. In view of its uncertain long-term durability and effec-
tiveness, as well as the increased surveillance burden,
EVAR is most appropriate for patients at increased risk
for conventional open aneurysm repair.
7. EVAR may be the preferred treatment method for
older, high-risk patients, those with “hostile” abdo-
mens, or other clinical circumstances likely to increase
the risk of conventional open repair, if their anatomy is
appropriate.
8. Use of EVAR in patients with unsuitable anatomy
markedly increases the risk of adverse outcomes, need
for conversion to open repair, or AAA rupture.
9. At present, there does not appear to be any justification
that EVAR should change the accepted size thresholds
for intervention in most patients.
10. In choosing between open repair and EVAR, patient
preference is of great importance. It is essential that the
patients be well informed to make such choices.
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